SEC Form D · Amendment · filed November 5, 2018
VenatoRx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Christopher J. Burns · Malvern, PAExec · DirectorCarlo J. Rizzuto · Malvern, PADirectorDaniel C. Pevear · Malvern, PAExecMichael J. Diem · Malvern, PADirectorVincent J. Milano · Malvern, PADirectorEzra J. Felker · Malvern, PAExecShelley J. Chu · Malvern, PADirectorGregg Johnson · Santa Barbara, CAExecRobert F. Friel · New York, NYExecSteven Frankel · New York, NYDirectorAlain I. Karaoglan · New York, NYDirectorJoseph Lonsdale · San Francisco, CADirectorMark Suster · Santa Barbara, CAExec · DirectorBrett Queener · Santa Barbara, CADirectorWilliam O'Halloran · Boston, MAExec · DirectorJohn M. Yanchek · Boston, MADirectorNicholas A. Sinatra · Buffalo, NYExecAnthony R. Nanula · Buffalo, NYDirectorPatrick Finucane · Buffalo, NYDirectorAndrew S. Zimmerman · Austin, TXExecTrevor S. Dallas · Austin, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗